Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure

NCT00416897

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +21 more
Locations
  • Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom
  • Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Birmingham, England, United Kingdom
  • Good Hope Hospital Birmingham, England, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, England, United Kingdom
View all 39 locations
View Trial Details
Completed

Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma

NCT00608374

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations
  • Canberra Hospital Garran, Australian Capital Territory, Australia
  • Newcastle Mater Misericordiae Hospital Waratah, New South Wales, Australia
  • Princess Alexandra Hospital Brisbane, Queensland, Australia
  • Queen Elizabeth Hospital Woodville, South Australia, Australia
View all 49 locations
View Trial Details
Completed

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia

NCT00005609

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 69 locations
View Trial Details
Completed

Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma

NCT00934154

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Baskent University School of Medicine Education and Research Hospital, Hematology Department Adana, Turkey (Türkiye)
  • Ankara Numune Education and Research Hospital,Hematology Department Ankara, Turkey (Türkiye)
  • Ankara University School of Medicine, Hematology Department Ankara, Turkey (Türkiye)
  • Gazi University School of Medicine, Hematology Department Ankara, Turkey (Türkiye)
View Trial Details
Completed

Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma

NCT00315757

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Scripps Clinic Medical Group, Inc. La Jolla, California, United States
  • Cancer and Blood Disorders Center Lecanto, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 20 locations
View Trial Details

Related conditions